Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2022-08-30 Share Issue/Capital Cha…
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
Cleansing Notice 1 page 107.8KB
Share Issue/Capital Change Classification · 95% confidence The document is a Section 708A(5) Cleansing Notice under the Corporations Act, announcing the issue of new shares by HeraMED Limited. It references compliance with disclosure requirements and the issuance of shares under ASX Listing Rule 7.1. The document is short (2218 characters) and serves as a formal announcement of a share issue event rather than a detailed financial report or presentation. It does not contain financial statements or detailed analysis, nor is it a report publication or certification. Therefore, it fits the category of a Share Issue/Capital Change announcement.
2022-08-30 English
Appendix 4D and Half Year Report 28 pages 873.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ASX APPENDIX 4D HALF-YEAR FINANCIAL REPORT TO 30 JUNE 2022' and contains detailed financial data for the half-year ended 30 June 2022, including revenues, profit/loss, net tangible assets per share, and dividend details. It includes a directors' report, auditor's review report, consolidated financial statements, and notes to the financial statements. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content and structure align with a comprehensive interim or quarterly financial report. The presence of half-year financial results and detailed financial statements confirms this is an Interim / Quarterly Report (IR). H1 2022
2022-08-25 English
HeraMED Completes $4 Million Private Placement 3 pages 176.9KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 24 August 2022 regarding HeraMED completing a private placement raising AU$4.0 million. It details the terms of the placement, including share pricing, attaching options, use of proceeds, and shareholder approval requirements. The content focuses on capital raising activities and financing updates rather than financial results, management changes, or regulatory filings. The document length is 6940 characters, which is sufficient for a detailed announcement but does not contain financial statements or earnings data. Therefore, this document fits the category of Capital/Financing Update (CAP).
2022-08-23 English
Proposed issue of securities - HMD 7 pages 32.1KB
Capital/Financing Update Classification · 95% confidence The document is an announcement from Heramed Limited dated 24/8/2022 regarding a proposed issue of securities, including details about the number and type of securities, issue price, conditions, and approvals required. It references ASX Listing Rules and placement capacities. The content is focused on informing the market about a capital raising event through a placement or other issue of shares and options. There are no financial statements, management discussion, or audit information present. The document is a regulatory announcement about a capital raising event, which fits the category of Capital/Financing Update (CAP). The document length is 9240 characters, which is substantive and contains detailed information about the proposed securities issue, not just a brief notice or a report publication announcement. Therefore, the correct classification is CAP with high confidence.
2022-08-23 English
Trading Halt 2 pages 225.5KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from HeraMED Limited regarding a trading halt requested to consider, plan, and execute a capital raising. It explicitly states the halt is pending a capital raising announcement. There are no financial statements, detailed financial data, or report content. The document is short (2094 characters) and serves as an announcement of a trading halt related to capital raising activities, not the capital raising update itself. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes.
2022-08-21 English
Notification of cessation of securities - HMD 4 pages 24.2KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the expiry of options (unexercised convertible securities) for Heramed Limited. It provides specifics on the securities that have ceased, the date of cessation, and the updated issued capital following these changes. There is no financial performance data, no management discussion, no earnings information, and no mention of a report being attached or published. The document is an official announcement regarding changes in the company's securities, specifically the cessation of certain options. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as cessation or expiry of securities.
2022-08-17 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.